CN106544563B - A kind of biodegradable Mg-Ca-Mn-Sn magnesium alloy materials and preparation method and application - Google Patents
A kind of biodegradable Mg-Ca-Mn-Sn magnesium alloy materials and preparation method and application Download PDFInfo
- Publication number
- CN106544563B CN106544563B CN201610958729.9A CN201610958729A CN106544563B CN 106544563 B CN106544563 B CN 106544563B CN 201610958729 A CN201610958729 A CN 201610958729A CN 106544563 B CN106544563 B CN 106544563B
- Authority
- CN
- China
- Prior art keywords
- biodegradable
- magnesium alloy
- magnesium
- purity
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229910000861 Mg alloy Inorganic materials 0.000 title claims abstract description 47
- 229910018645 Mn—Sn Inorganic materials 0.000 title claims abstract description 29
- 239000000956 alloy Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000011777 magnesium Substances 0.000 claims abstract description 21
- 229910052718 tin Inorganic materials 0.000 claims abstract description 14
- 239000007943 implant Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 229910052748 manganese Inorganic materials 0.000 claims abstract description 11
- 239000012535 impurity Substances 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000000137 annealing Methods 0.000 claims abstract description 5
- 238000001192 hot extrusion Methods 0.000 claims abstract description 4
- 238000005266 casting Methods 0.000 claims abstract description 3
- 229910045601 alloy Inorganic materials 0.000 claims description 15
- 239000011135 tin Substances 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 14
- 229910052749 magnesium Inorganic materials 0.000 claims description 14
- 229910052751 metal Inorganic materials 0.000 claims description 13
- 239000002184 metal Substances 0.000 claims description 13
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 12
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 10
- 238000001125 extrusion Methods 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 239000007789 gas Substances 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 6
- 229910002804 graphite Inorganic materials 0.000 claims description 6
- 239000010439 graphite Substances 0.000 claims description 6
- 238000000265 homogenisation Methods 0.000 claims description 6
- 238000007670 refining Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229910052786 argon Inorganic materials 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 230000001681 protective effect Effects 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 abstract description 7
- 239000012567 medical material Substances 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract description 2
- 230000000399 orthopedic effect Effects 0.000 abstract description 2
- 238000003723 Smelting Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 description 8
- 239000007769 metal material Substances 0.000 description 5
- 230000007797 corrosion Effects 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 231100000701 toxic element Toxicity 0.000 description 2
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C23/00—Alloys based on magnesium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C1/00—Making non-ferrous alloys
- C22C1/02—Making non-ferrous alloys by melting
- C22C1/03—Making non-ferrous alloys by melting using master alloys
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
- C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
- C22F1/06—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of magnesium or alloys based thereon
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Metallurgy (AREA)
- Mechanical Engineering (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种生物可降解Mg‑Ca‑Mn‑Sn镁合金材料及其制备方法与应用,所述生物可降解Mg‑Ca‑Mn‑Sn镁合金材料按照质量百分比由以下组分制备而成:Ca 0.5~3%,Mn 0.1~2%,Sn 1~5%,其余为Mg以及由原材料带入的不可避免的杂质元素。具体制备方法包括原材料的熔炼、浇铸成型、均匀化退火处理、热挤压加工。本发明的生物可降解Mg‑Ca‑Mn‑Sn镁合金对人体无任何毒性,力学性能良好,制备方法简单且成本低,可以根据需求制备出不同尺寸和截面要求的板状、棒状材料,可用作骨板、骨钉等骨科植入物和心血管支架等医学材料的制备。The invention discloses a biodegradable Mg-Ca-Mn-Sn magnesium alloy material and its preparation method and application. The biodegradable Mg-Ca-Mn-Sn magnesium alloy material is prepared from the following components according to the mass percentage Composition: Ca 0.5~3%, Mn 0.1~2%, Sn 1~5%, the rest is Mg and unavoidable impurity elements brought by raw materials. The specific preparation method includes smelting of raw materials, casting molding, homogenizing annealing treatment, and hot extrusion processing. The biodegradable Mg-Ca-Mn-Sn magnesium alloy of the present invention has no toxicity to the human body, good mechanical properties, simple preparation method and low cost, and plate-shaped and rod-shaped materials with different sizes and cross-section requirements can be prepared according to requirements. It is used in the preparation of orthopedic implants such as bone plates and bone nails and medical materials such as cardiovascular stents.
Description
技术领域technical field
本发明属于医学植入材料技术领域,涉及一种生物可降解Mg-Ca-Mn-Sn镁合金材料及其制备方法与应用。The invention belongs to the technical field of medical implant materials, and relates to a biodegradable Mg-Ca-Mn-Sn magnesium alloy material and a preparation method and application thereof.
背景技术Background technique
目前,临床上普遍使用的传统医用金属材料主要有医用不锈钢、医用钛合金、医用钴合金等,但这些材料作为医学植入物往往存在某些隐患,如:在人体体液环境中发生腐蚀会产生有毒元素的释放;传统医用金属材料的弹性模量高于人体骨骼的弹性模量;需要进行二次手术将其取出。At present, the traditional medical metal materials commonly used clinically mainly include medical stainless steel, medical titanium alloy, and medical cobalt alloy. The release of toxic elements; the modulus of elasticity of traditional medical metal materials is higher than that of human bones; a secondary operation is required to remove it.
镁合金作为医用金属材料可追溯到100多年前,但是,由于镁合金的耐蚀性较差,在人体内降解速度过快无法满足作为医学植入物的性能要求,因此限制了镁合金作为医学植入物的广泛应用。但早期的临床应用已经证实了镁合金作为医用材料的可行性。Magnesium alloys as medical metal materials can be traced back more than 100 years ago. However, due to the poor corrosion resistance of magnesium alloys, the degradation rate in the human body is too fast to meet the performance requirements of medical implants, thus limiting the use of magnesium alloys as medical implants. Wide application of implants. But early clinical applications have confirmed the feasibility of magnesium alloys as medical materials.
随着不同的加工方法和表面处理技术的发展和成熟,镁合金的耐腐蚀性能和力学性能都得到了很大的提高。最近几年,世界各国有更多的研究者开始进行镁合金作为生物材料的研究。许多的体内、体外实验结果也已证明,可降解镁合金作为医学植入材料有很多的杰出表现。With the development and maturity of different processing methods and surface treatment technologies, the corrosion resistance and mechanical properties of magnesium alloys have been greatly improved. In recent years, more and more researchers around the world have begun to study magnesium alloys as biomaterials. Many in vivo and in vitro experimental results have also proved that degradable magnesium alloys have many outstanding performances as medical implant materials.
与传统医用金属材料相比,生物可降解镁合金作为新一代的医用金属材料的研究热点,具有独一无二的可降解性及生物兼容性,因此在可降解医学植入物的应用方面蕴藏巨大的潜力。镁是人体内不可或缺的营养元素,其弹性模量和密度更接近于人骨,可避免产生“应力遮挡效应”,并且具有良好的骨诱导性能,能促进骨头的生长和愈合。而且,高强度镁合金具有良好的机械性能,符合理想医用植入物的性能要求。当骨愈合后,镁合金植入物无需取出,避免了二次手术给患者带来的伤害和额外的经济负担。Compared with traditional medical metal materials, biodegradable magnesium alloys, as a research hotspot of a new generation of medical metal materials, have unique degradability and biocompatibility, so they have great potential in the application of degradable medical implants . Magnesium is an indispensable nutritional element in the human body. Its elastic modulus and density are closer to human bone, which can avoid the "stress shielding effect", and has good osteoinductive properties, which can promote bone growth and healing. Moreover, high-strength magnesium alloys have good mechanical properties, which meet the performance requirements of ideal medical implants. After the bone is healed, the magnesium alloy implant does not need to be removed, which avoids the injury and additional economic burden of the second operation on the patient.
发明内容Contents of the invention
本发明的目的是提供一种对人体无任何毒性、力学性能良好、制备方法简单且成本较低的生物可降解Mg-Ca-Mn-Sn镁合金材料及其制备方法与应用。The object of the present invention is to provide a biodegradable Mg-Ca-Mn-Sn magnesium alloy material which has no toxicity to human body, good mechanical properties, simple preparation method and low cost, and its preparation method and application.
本发明的目的是通过以下技术方案实现的:The purpose of the present invention is achieved through the following technical solutions:
一种生物可降解Mg-Ca-Mn-Sn镁合金材料,按照质量百分比由以下组分制备而成:Ca 0.5~3%,Mn 0.1~2%,Sn 1~5%,其余为Mg以及由原材料带入的不可避免的杂质元素。A biodegradable Mg-Ca-Mn-Sn magnesium alloy material is prepared from the following components according to the mass percentage: Ca 0.5-3%, Mn 0.1-2%, Sn 1-5%, the rest is Mg and Unavoidable impurity elements introduced by raw materials.
一种上述生物可降解Mg-Ca-Mn-Sn镁合金材料的制备方法,包括以下步骤:A preparation method of the above-mentioned biodegradable Mg-Ca-Mn-Sn magnesium alloy material, comprising the following steps:
(1)以高纯镁锭、高纯钙粒、Mg-10%Mn中间合金和高纯锡粒为原材料,按上述质量百分比进行合金原料的配置,熔炼时采用石墨坩埚并持续通入高纯氩气作为保护气体;(1) Using high-purity magnesium ingots, high-purity calcium particles, Mg-10%Mn intermediate alloys and high-purity tin particles as raw materials, the alloy raw materials are configured according to the above mass percentages, and graphite crucibles are used for melting and high-purity argon gas is continuously introduced as protection. gas;
(2)将石墨坩埚预热到450~550℃时,在坩埚的底部均匀地撒上覆盖剂,加入小块高纯镁锭,升温至700~740℃并保温10~30min,待高纯镁锭完全熔化后,除去表面浮渣,熔液升温至760~780℃依次加入高纯钙粒、锡粒和Mg-Mn中间合金,搅拌3~5次,静置10~20min;(2) When the graphite crucible is preheated to 450-550°C, evenly sprinkle the covering agent on the bottom of the crucible, add a small piece of high-purity magnesium ingot, raise the temperature to 700-740°C and keep it warm for 10-30min, after the high-purity magnesium ingot is completely melted , remove surface scum, heat up the melt to 760-780°C, add high-purity calcium particles, tin particles and Mg-Mn master alloy in sequence, stir 3-5 times, and let stand for 10-20 minutes;
(3)待全部金属熔化后,金属溶液降温至735~745℃,加入精炼剂并不断搅拌,搅拌3~5min后,金属溶液进行20~40min的静置精炼;(3) After all the metal is melted, the temperature of the metal solution is lowered to 735-745°C, and the refining agent is added and stirred continuously. After stirring for 3-5 minutes, the metal solution is subjected to static refining for 20-40 minutes;
(4)待金属溶液降温至690~710℃时,然后浇入到预热温度为340~360℃的金属模中,待铸锭冷却后获得铸态生物可降解Mg-Ca-Mn-Sn镁合金铸锭。(4) When the metal solution is cooled to 690-710°C, it is then poured into a metal mold with a preheating temperature of 340-360°C, and the as-cast biodegradable Mg-Ca-Mn-Sn magnesium is obtained after the ingot is cooled alloy ingot.
进一步地,铸态生物可降解Mg-Ca-Mn-Sn镁合金铸锭在350~450℃下进行6~24h的均匀化退火处理,获得均匀化态生物可降解Mg-Ca-Mn-Sn镁合金。Further, the as-cast biodegradable Mg-Ca-Mn-Sn magnesium alloy ingot is subjected to homogenization annealing treatment at 350-450°C for 6-24 hours to obtain homogenized biodegradable Mg-Ca-Mn-Sn magnesium alloy.
进一步地,选用不同尺寸和成形截面的模具,将均匀化退火处理后的Mg-Ca-Mn-Sn镁合金进行常规热挤压,获得所需不同挤压比的棒状或板条状挤压态镁合金,挤压温度为250~400℃,挤压速度为0.5~8mm/s。Further, the Mg-Ca-Mn-Sn magnesium alloy after homogenization annealing is subjected to conventional hot extrusion by using dies with different sizes and forming sections to obtain rod-like or lath-like extruded states with different extrusion ratios. For magnesium alloy, the extrusion temperature is 250-400°C, and the extrusion speed is 0.5-8mm/s.
与现有技术相比,本发明具有的优点和有益效果如下:Compared with prior art, the advantages and beneficial effects that the present invention has are as follows:
(1)本发明中的Mg-Ca-Mn-Sn镁合金采用无毒微量合金元素添加设计,以确保镁合金在人体内发生降解后不会产生有毒元素,同时合金元素的添加可以改善镁合金作为医学植入材料的力学性能和耐腐蚀性能,可以保证镁合金作为植入物所发挥的作用。(1) The Mg-Ca-Mn-Sn magnesium alloy in the present invention is designed with the addition of non-toxic trace alloy elements to ensure that no toxic elements will be produced after the magnesium alloy degrades in the human body, and the addition of alloy elements can improve the magnesium alloy As a medical implant material, the mechanical properties and corrosion resistance can ensure the role of magnesium alloy as an implant.
(2)本发明中的生物可降解镁合金选用Mg、Ca、Sn和Mg-10%Mn中间合金作为原材料,其中Mg、Ca、Mn、Sn是人体不可缺少的营养元素,随着镁合金在人体内的自动降解,所释放出的无毒合金元素会被人体吸收,避免合金元素引起的生物安全性问题。与此同时,Ca可以改善镁合金的抗蠕变性能;Mn具有细化晶粒的作用;Sn有利于身体的生长发育,可以促进伤口的愈合,参与影响血红蛋白的功能,同时,Sn添加到镁合金中可以细化晶粒,提高镁合金的力学性能和耐腐蚀性能。(2) The biodegradable magnesium alloy in the present invention selects Mg, Ca, Sn and Mg-10%Mn master alloy as raw materials, wherein Mg, Ca, Mn and Sn are indispensable nutritional elements for the human body. Automatic degradation in the human body, the released non-toxic alloy elements will be absorbed by the human body, avoiding the biological safety problems caused by alloy elements. At the same time, Ca can improve the creep resistance of magnesium alloys; Mn has the effect of refining grains; Sn is beneficial to the growth and development of the body, can promote wound healing, and participates in affecting the function of hemoglobin. At the same time, Sn added to magnesium The grains in the alloy can be refined to improve the mechanical properties and corrosion resistance of the magnesium alloy.
(3)本发明的生物可降解Mg-Ca-Mn-Sn镁合金的制备方法简单且成本低,可以根据需求制备出不同尺寸和截面要求的板状、棒状材料,可用作骨板、骨钉等骨科植入物和心血管支架等医学材料的制备。(3) The preparation method of the biodegradable Mg-Ca-Mn-Sn magnesium alloy of the present invention is simple and low in cost, and plate-shaped and rod-shaped materials with different sizes and cross-section requirements can be prepared according to requirements, and can be used as bone plates, bone Preparation of orthopedic implants such as nails and medical materials such as cardiovascular stents.
具体实施方式Detailed ways
下面结合实施例对本发明的技术方案作进一步的说明,但并不局限于此,凡是对本发明技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围,均应涵盖在本发明的保护范围中。The technical solution of the present invention will be further described below in conjunction with the examples, but it is not limited thereto. Any modification or equivalent replacement of the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention should be covered by the present invention within the scope of protection.
实施例1:Example 1:
本实施例中的生物可降解Mg-Ca-Mn-Sn镁合金材料按照质量百分比由以下组分制备而成:Ca 0.5%,Mn 1%,Sn 2%,其余为Mg以及由原材料带入的不可避免的杂质元素。具体制备步骤如下:The biodegradable Mg-Ca-Mn-Sn magnesium alloy material in this example is prepared from the following components according to the mass percentage: Ca 0.5%, Mn 1%, Sn 2%, the rest is Mg and the Unavoidable impurity elements. Concrete preparation steps are as follows:
(1)以高纯镁锭、高纯钙粒、Mg-10%Mn中间合金和高纯锡粒为原材料,按上述质量百分比进行合金原料的配置,熔炼时采用石墨坩埚并持续通入高纯氩气作为保护气体;(1) Using high-purity magnesium ingots, high-purity calcium particles, Mg-10%Mn intermediate alloys and high-purity tin particles as raw materials, the alloy raw materials are configured according to the above mass percentages, and graphite crucibles are used for melting and high-purity argon gas is continuously introduced as protection. gas;
(2)将石墨坩埚预热到500℃时,在坩埚的底部均匀地撒上适量的RJ-2覆盖剂,避免产生燃烧现象。然后加入小块高纯镁锭,升温至720±20℃并保温20min,待高纯镁锭完全熔化后,除去表面浮渣,熔液升温至780℃依次加入高纯钙粒、锡粒和Mg-Mn中间合金,搅拌4次,静置15min;(2) When the graphite crucible is preheated to 500°C, sprinkle an appropriate amount of RJ-2 covering agent evenly on the bottom of the crucible to avoid burning. Then add a small piece of high-purity magnesium ingot, raise the temperature to 720±20°C and keep it warm for 20 minutes. After the high-purity magnesium ingot is completely melted, remove the surface scum, and heat the melt to 780°C to add high-purity calcium particles, tin particles and Mg-Mn master alloy in turn. , stirred 4 times, and stood still for 15 minutes;
(3)待全部金属熔化后,金属溶液降温至740±5℃,加入适量的RJ-5精炼剂并不断搅拌,避免产生燃烧现象,搅拌5min后,金属溶液进行30min的静置精炼;(3) After all the metals are melted, cool down the metal solution to 740±5°C, add an appropriate amount of RJ-5 refining agent and keep stirring to avoid burning. After stirring for 5 minutes, the metal solution should be refined for 30 minutes;
(4)待金属溶液降温至700±10℃时,然后浇入到预热温度为350℃的金属模中,待铸锭冷却后获得铸态生物可降解Mg-Ca-Mn-Sn镁合金铸锭。浇铸过程匀速缓慢,并在金属溶液表面不断输送流动的氩气进行保护。(4) When the metal solution is cooled to 700±10°C, it is poured into a metal mold with a preheating temperature of 350°C, and the as-cast biodegradable Mg-Ca-Mn-Sn magnesium alloy is obtained after the ingot is cooled. ingot. The casting process is uniform and slow, and flowing argon is continuously delivered on the surface of the molten metal for protection.
实施例2:Example 2:
本实施例与实施例1不同的是,铸态生物可降解Mg-Ca-Mn-Sn镁合金铸锭在400℃下进行12h的均匀化退火处理,获得均匀化态生物可降解Mg-Ca-Mn-Sn镁合金。The difference between this example and Example 1 is that the as-cast biodegradable Mg-Ca-Mn-Sn magnesium alloy ingot is subjected to homogenization annealing at 400°C for 12 hours to obtain a homogenized biodegradable Mg-Ca- Mn-Sn magnesium alloy.
实施例3:Example 3:
本实施例与实施例2不同的是,选用不同尺寸和成形截面的模具,将均匀化退火处理后的Mg-Ca-Mn-Sn镁合金进行常规热挤压,获得所需不同挤压比的棒状或板条状挤压态镁合金,挤压温度为300℃,挤压速度为5mm/s。The difference between this embodiment and embodiment 2 is that dies with different sizes and forming sections are selected, and the homogenized annealed Mg-Ca-Mn-Sn magnesium alloy is subjected to conventional hot extrusion to obtain the desired extrusion ratio. Rod or lath extruded magnesium alloy, the extrusion temperature is 300°C, and the extrusion speed is 5mm/s.
实施例4:Example 4:
本实施例与实施例1、2或3不同的是,生物可降解Mg-Ca-Mn-Sn镁合金材料按照质量百分比由以下组分制备而成:Ca 1%,Mn 1.5%,Sn 3%,其余为Mg以及由原材料带入的不可避免的杂质元素。The difference between this example and Example 1, 2 or 3 is that the biodegradable Mg-Ca-Mn-Sn magnesium alloy material is prepared from the following components according to the mass percentage: Ca 1%, Mn 1.5%, Sn 3% , and the rest are Mg and unavoidable impurity elements brought in by the raw materials.
实施例5:Example 5:
本实施例与实施例1、2或3不同的是,生物可降解Mg-Ca-Mn-Sn镁合金材料按照质量百分比由以下组分制备而成:Ca 1.25%,Mn 0.8%,Sn 1%,其余为Mg以及由原材料带入的不可避免的杂质元素。The difference between this example and Example 1, 2 or 3 is that the biodegradable Mg-Ca-Mn-Sn magnesium alloy material is prepared from the following components according to the mass percentage: Ca 1.25%, Mn 0.8%, Sn 1% , and the rest are Mg and unavoidable impurity elements brought in by the raw materials.
实施例6:Embodiment 6:
本实施例与实施例1、2或3不同的是,生物可降解Mg-Ca-Mn-Sn镁合金材料按照质量百分比由以下组分制备而成:Ca 2%,Mn 0.5%,Sn 2%,其余为Mg以及由原材料带入的不可避免的杂质元素。The difference between this example and Example 1, 2 or 3 is that the biodegradable Mg-Ca-Mn-Sn magnesium alloy material is prepared from the following components according to the mass percentage: Ca 2%, Mn 0.5%, Sn 2% , and the rest are Mg and unavoidable impurity elements brought in by the raw materials.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610958729.9A CN106544563B (en) | 2016-11-04 | 2016-11-04 | A kind of biodegradable Mg-Ca-Mn-Sn magnesium alloy materials and preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610958729.9A CN106544563B (en) | 2016-11-04 | 2016-11-04 | A kind of biodegradable Mg-Ca-Mn-Sn magnesium alloy materials and preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106544563A CN106544563A (en) | 2017-03-29 |
CN106544563B true CN106544563B (en) | 2018-06-19 |
Family
ID=58393566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610958729.9A Expired - Fee Related CN106544563B (en) | 2016-11-04 | 2016-11-04 | A kind of biodegradable Mg-Ca-Mn-Sn magnesium alloy materials and preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106544563B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109972007A (en) * | 2019-03-20 | 2019-07-05 | 北京科技大学 | A biodegradable Mg-Zn-Ca-M staple material and its preparation method |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11578396B2 (en) * | 2017-07-18 | 2023-02-14 | National Institute For Materials Science | Magnesium-based alloy wrought product and method for producing same |
CN108103335A (en) * | 2017-09-12 | 2018-06-01 | 广东省材料与加工研究所 | A kind of method for refining Mg-Zn systems alloy grain |
CN108570585B (en) * | 2018-06-13 | 2020-01-03 | 河南科技大学 | Corrosion-resistant magnesium alloy and preparation method thereof |
CN111218596A (en) * | 2020-01-15 | 2020-06-02 | 太原科技大学 | A kind of short-term degradable magnesium alloy material for intrauterine stent and preparation method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813966A (en) * | 2012-08-29 | 2012-12-12 | 哈尔滨工程大学 | Medical degradable magnesium alloy bone-fixing screw |
CN105401033A (en) * | 2015-12-28 | 2016-03-16 | 太原理工大学 | High strength and toughness anti-corrosion biomedical magnesium alloy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2540742T3 (en) * | 2008-06-06 | 2015-07-13 | Synthes Gmbh | Absorbable magnesium alloy |
-
2016
- 2016-11-04 CN CN201610958729.9A patent/CN106544563B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813966A (en) * | 2012-08-29 | 2012-12-12 | 哈尔滨工程大学 | Medical degradable magnesium alloy bone-fixing screw |
CN105401033A (en) * | 2015-12-28 | 2016-03-16 | 太原理工大学 | High strength and toughness anti-corrosion biomedical magnesium alloy |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109972007A (en) * | 2019-03-20 | 2019-07-05 | 北京科技大学 | A biodegradable Mg-Zn-Ca-M staple material and its preparation method |
Also Published As
Publication number | Publication date |
---|---|
CN106544563A (en) | 2017-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106544563B (en) | A kind of biodegradable Mg-Ca-Mn-Sn magnesium alloy materials and preparation method and application | |
CN107557632B (en) | Degradable biomedical Mg-Zn-Zr-Nd alloy material and preparation method thereof | |
CN104328318B (en) | A kind of preparation method of high anti-corrosion biodegradable magnesium alloy | |
CN105925848B (en) | A kind of biological medical degradable kirsite inner implantation material and its sheet material preparation method | |
CN103184379B (en) | Biodegradable Mg-Gd-Zn-Ag-Zr series magnesium alloy and preparation method thereof | |
CN105154735B (en) | Degradable biomedical Mg-Nd-Sr magnesium alloy as well as preparation method and application thereof | |
CN104630587A (en) | Degradable magnesium alloy plate and bar for fracture internal fixation and preparation methods thereof | |
CN103667838B (en) | Mg-Sn-Mn system wrought magnesium alloy and preparation method thereof | |
CN104328312A (en) | Medical biodegradable zinc alloy and preparation method thereof | |
CN107435116A (en) | A kind of magnesium alloy biological implantation material and preparation method thereof | |
CN105401033B (en) | High strength and toughness anti-corrosion biomedical magnesium alloy | |
CN103184380B (en) | Biodegradable Mg-Gd-Zn-Sr-Zr series magnesium alloy and preparation method thereof | |
CN104164602A (en) | Preparation method of medical magnesium alloy capable of being evenly degraded | |
CN102258806A (en) | Degradable magnesium-base biomedical material for implantation in orthopaedics, and preparation method thereof | |
CN108411158B (en) | A kind of biodegradable Zn-Mg-Zr alloy material, preparation method and application | |
CN113444919A (en) | Zinc alloy material for degradable cardiovascular stent and preparation method thereof | |
CN111733353B (en) | A kind of absorbable bone fixation medical Mg-Ag-Ca alloy and preparation method thereof | |
CN113106312B (en) | Degradable medical alloy and preparation method and application thereof | |
CN108411173A (en) | A kind of bio-medical Mg-Sn-Zn-Sr magnesium alloys and preparation method thereof | |
CN114107712B (en) | A kind of medical magnesium-based composite rod and its preparation method | |
CN110656260A (en) | A kind of degradable medical Zn alloy material and preparation method thereof | |
CN108642359B (en) | High-strength rapid-degradation biomedical Mg-Zn-Zr-Fe alloy material and preparation method thereof | |
JP7590559B2 (en) | Rare earth element-free biodegradable magnesium alloy, its manufacturing method and use | |
CN111218596A (en) | A kind of short-term degradable magnesium alloy material for intrauterine stent and preparation method | |
CN115161513B (en) | A biomedical degradable alloy and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180619 |
|
CF01 | Termination of patent right due to non-payment of annual fee |